<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04127162</url>
  </required_header>
  <id_info>
    <org_study_id>CHF_NTproBNP</org_study_id>
    <nct_id>NCT04127162</nct_id>
  </id_info>
  <brief_title>Heart Failure Decompensation And In-Hospital Mortality</brief_title>
  <official_title>Short-Period Temporal Dispersion Repolarization Markers and In-Hospital Mortality in Decompensated Heart Failure: A Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Roma La Sapienza</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Roma La Sapienza</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Background and objectives Heart failure is a leading cause of morbidity and mortality
      worldwide and it is a major cause of emergency department access for cardiovascular disease
      patients. Aim of this study is to identify the markers, based on short-term temporal
      repolarization dispersion, capable to individuate decompensated chronic heart failure (CHF)
      patients at high mortality risk.

      Method: We will obtain the following variables from ECG monitor, via mobile phone, during
      5-minute recordings in decompensated CHF patients: RR, QT end (QTe), QT peak (QTp) and T peak
      to T end (Te) and we calculated mean, standard deviation (SD) and normalized index (N).
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">December 2019</start_date>
  <completion_date type="Anticipated">April 2020</completion_date>
  <primary_completion_date type="Anticipated">March 2020</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <target_duration>1 Month</target_duration>
  <primary_outcome>
    <measure>Mortality</measure>
    <time_frame>3 months</time_frame>
    <description>in-hospital mortality in decompensated heart failure patients</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Chronic Heart Failure</condition>
  <condition>Decompensated Heart Failure</condition>
  <condition>Morality</condition>
  <arm_group>
    <arm_group_label>alive</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>dead</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        decompensated heart failure patients admitted to the emergency department with dyspnea and
        other clinical signs of heart failure.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  at least one symptom or sign compatible with a decompensation and/or a previous
             documented history of CHF

        Exclusion Criteria:

          -  pneumonia

          -  pulmonary embolism
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>October 13, 2019</study_first_submitted>
  <study_first_submitted_qc>October 14, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 15, 2019</study_first_posted>
  <last_update_submitted>October 14, 2019</last_update_submitted>
  <last_update_submitted_qc>October 14, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 15, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Roma La Sapienza</investigator_affiliation>
    <investigator_full_name>Gianfranco Piccirillo</investigator_full_name>
    <investigator_title>professor</investigator_title>
  </responsible_party>
  <keyword>Temporal Dispersion of Repolarization Phase</keyword>
  <keyword>proBNP</keyword>
  <keyword>QTVI</keyword>
  <keyword>QT</keyword>
  <keyword>Tpeak-Tend</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

